Adefovir treatment for chronic hepatitis B in heart transplant recipients

Clinical Transplantation

Volumn 27, Issue 3, 2013, Pages

  Durante Mangoni, Emanuele ^a   Iossa, Domenico ^a   Pinto, Daniela ^a   Molaro, Rosa ^a   Agrusta, Federica ^a   Amarelli, Cristiano ^b   Ragone, Enrico ^a   Grimaldi, Maria ^a   Maiello, Ciro ^b   Utili, Riccardo ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b MONALDI HOSPITAL   (Italy)

Author keywords

Antiviral agents; Drug resistance; Liver diseases; Renal insufficiency; Viral

Indexed keywords

ADEFOVIR DIPIVOXIL; ALANINE AMINOTRANSFERASE; AZATHIOPRINE; CYCLOSPORIN A; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TENOFOVIR; TENOFOVIR DISOPROXIL; ADEFOVIR; ADENINE; ANTIVIRUS AGENT; PHOSPHONIC ACID DERIVATIVE; VIRUS DNA;

ABDOMINAL PAIN; ADULT; ANTIVIRAL THERAPY; ARTICLE; CARDIAC GRAFT REJECTION; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DECOMPENSATED LIVER CIRRHOSIS; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FATIGUE; FEMALE; FIBROSIS; GENE SEQUENCE; GENOTYPE; GLOMERULUS FILTRATION RATE; GRAFT RECIPIENT; HEART GRAFT; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HYPOPHOSPHATEMIA; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION TEST; LACTIC ACIDOSIS; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER FUNCTION TEST; MALE; NAUSEA; OUTCOME ASSESSMENT; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; SIDE EFFECT; STRUCTURAL GENE; TREATMENT DURATION; VIREMIA; VIRUS LOAD; ANALOGS AND DERIVATIVES; COMPLICATION; DRUG EFFECTS; FOLLOW UP; GENETICS; HEART DISEASES; HEART TRANSPLANTATION; HEPATITIS B, CHRONIC; MIDDLE AGED; POSTOPERATIVE COMPLICATION; PROGNOSIS; PROSPECTIVE STUDY; VIROLOGY;

ADENINE; ADULT; ANTIVIRAL AGENTS; DNA, VIRAL; FEMALE; FOLLOW-UP STUDIES; HEART DISEASES; HEART TRANSPLANTATION; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; MALE; MIDDLE AGED; ORGANOPHOSPHONATES; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; PROSPECTIVE STUDIES; VIRAL LOAD;

EID: 84878651177     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/ctr.12109     Document Type: Article

References (25)

1. De Man RA, M Balle AH, Jonkman FA et al. Patient to patient hepatitis B transmission during heart biopsy procedures. A report of the European working party on viral hepatitis in heart transplant recipients. J Hosp Infect 1996: 34: 71.
2. Osterhaus AD, Vos MC, Balk AH et al. Transmission of hepatitis B virus among heart transplant recipients during endomyocardial biopsy procedures. J Heart Lung Transplant 1998: 17: 158.
3. Cadranel JF, Grippon P, Lunel F et al. Chronic liver dysfunction in heart transplant recipients, with special reference to viral B, C, and non-A, non-B, non-C hepatitis. A retrospective study in 80 patients with follow-up of 60 months. Transplantation 1991: 52: 645.
4. Lunel F, Robert C, Munier P et al. Hepatitis virus infections in heart transplant recipients. Biomed Pharmacother 1995: 49: 125.
5. Lunel F, Cadranel JF, Rosenheim M et al. Hepatitis virus infections in heart transplant recipients: epidemiology, natural history, characteristics, and impact on survival. Gastroenterology 2000: 119: 1064.
6. Fagiuoli S, Minniti F, Pevere S et al. HBV and HCV infections in heart transplant recipients. J Heart Lung Transplant 2001: 20: 718.
7. Wang SS, Chou NK, Chi NH et al. Successful treatment of hepatitis B virus infection with lamivudine after heart transplantation. Transplant Proc 2006: 38: 2138.
8. Wedemeyer H, Pethig K, Wagner D et al. Long-term outcome of chronic hepatitis B in heart transplant recipients. Transplantation 1998: 66: 1347.
9. Hosenpud JD, Pamidi SR, Fiol BS, Cinquegrani MP, Keck BM. Outcomes in patients who are hepatitis B surface antigen-positive before transplantation: an analysis and study using the joint ISHLT/UNOS thoracic registry. J Heart Lung Transplant 2000: 19: 781.
10. Wedemeyer H, Pethig K, Manns MP, Boker KH. Hepatitis B infection in heart transplant patients. Gastroenterology 2001: 120: 1311.
11. Hoffmann CJ, Subramanian AK, Cameron AM, Engels EA. Incidence and risk factors for hepatocellular carcinoma after solid organ transplantation. Transplantation 2008: 86: 784.
12. Haji SA, Avery RK, Yamani MH et al. Donor or recipient hepatitis B seropositivity is associated with allograft vasculopathy. J Heart Lung Transplant 2006: 25: 294.
13. Zampino R, Marrone A, Ragone E et al. Heart transplantation in patients with chronic hepatitis B: clinical evolution, molecular analysis, and effect of treatment. Transplantation 2005: 80: 1340.
14. Liu CJ, Lai MY, Lee PH et al. Lamivudine treatment for hepatitis B reactivation in HBsAg carriers after organ transplantation: a 4-year experience. J Gastroenterol Hepatol 2001: 16: 1001.
15. Lampertico P, Viganò M, Manenti E, Iavarone M, Lunghi G, Colombo M. Adefovir rapidly suppresses hepatitis B in HBeAg-negative patients developing genotypic resistance to lamivudine. Hepatology 2005: 42: 1414.
16. Potthoff A, Tillmann HL, Bara C et al. Improved outcome of chronic hepatitis B after heart transplantation by long-term antiviral therapy. J Viral Hepat 2006: 13: 734.
17. Wiegand J, Wedemeyer H, Finger A et al. A decline in hepatitis B virus surface antigen (HBsAg) predicts clearance, but does not correlate with quantitative HBeAg or HBV DNA levels. Antivir Ther 2008: 13: 547.
18. Knodell RG, Ishak KG, Black WC et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981: 1: 431.
19. Scheuer PJ. Classification of chronic viral hepatitis: a need for reassessment. J Hepatol 1991: 13: 372.
20. Levitsky J, Doucette K. Viral hepatitis in solid organ transplant recipients. Am J Transplant 2009: 9(Suppl 4): S116.
21. Daudé M, Rostaing L, Sauné K et al. Tenofovir therapy in hepatitis B virus-positive solid-organ transplant recipients. Transplantation 2011: doi:10.1097/TP.0b013e3182100f59.
22. Schiff ER, Lai CL, Hadziyannis S et al. Adefovir dipivoxil therapy for lamivudine-resistant hepatitis B in pre- and post-liver transplantation patients. Hepatology 2003: 38: 1419.
23. Neff GW, O'Brien CB, Nery J et al. Outcomes in liver transplant recipients with hepatitis B virus: resistance and recurrence patterns from a large transplant center over the last decade. Liver Transpl 2004: 10: 1372.
24. Bárcena R, Del Campo S, Moraleda G et al. Study on the efficacy and safety of adefovir dipivoxil treatment in post-liver transplant patients with hepatitis B virus infection and lamivudine-resistant hepatitis B virus. Transplant Proc 2005: 37: 3960.
25. Wang HS, Han SB. Management of hepatitis B in special patient populations. Clin Liver Dis 2010: 14: 505.